XRpro Sciences has acquired 1 company.
XRpro Sciences has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).
One Kendall Square, Building 200, Suite 2,
Cambridge, Massachusetts
02139
United States,
(617) 294-9697
www.xrpro.com
| Date | Target |
Value
$mlns |
Transaction Type | Acquirer | Seller |
SRC
Link |
|---|---|---|---|---|---|---|
| 2015-07-02 |
Pfizer - Ion Channel and Transporter Drug R&D · Life Science
, United States Pfizer - Ion Channel and Transporter Drug R&D platform is a provider of comprehensive services for ion channel and transporter drug discovery, combining Icagen's industry-leading scientific expertise and extensive portfolio of assays and cell lines with XRpro Sciences' proprietary, label-free X-ray fluorescence technology. |
- | Divestiture | - |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
